Pluristem Therapeutics Inc. PSTI.TA Stock
Pluristem Therapeutics Inc. Price Chart
Pluristem Therapeutics Inc. PSTI.TA Financial and Trading Overview
| Pluristem Therapeutics Inc. stock price | 360.9 ILA |
| Previous Close | 360.9 ILA |
| Open | 355.5 ILA |
| Bid | 361 ILA x 32000 |
| Ask | 361.6 ILA x 849800 |
| Day's Range | 358 - 370 ILA |
| 52 Week Range | 348.5 - 1122 ILA |
| Volume | 42.33K ILA |
| Avg. Volume | 61.92K ILA |
| Market Cap | 116.97M ILA |
| Beta (5Y Monthly) | 1.912728 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 ILA |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PSTI.TA Valuation Measures
| Enterprise Value | 85.15M ILA |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 499.8672 |
| Price/Book (mrq) | 306.96097 |
| Enterprise Value/Revenue | 363.903 |
| Enterprise Value/EBITDA | -1.849 |
Trading Information
Pluristem Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 1.912728 |
| 52-Week Change | -65.41% |
| S&P500 52-Week Change | -16.87% |
| 52 Week High | 1122 ILA |
| 52 Week Low | 348.5 ILA |
| 50-Day Moving Average | 403.51 ILA |
| 200-Day Moving Average | 572.15 ILA |
PSTI.TA Share Statistics
| Avg. Volume (3 month) | 61.92K ILA |
| Avg. Daily Volume (10-Days) | 5.77K ILA |
| Shares Outstanding | 32.35M |
| Float | 27.59M |
| Short Ratio | N/A |
| % Held by Insiders | 7.28% |
| % Held by Institutions | 12.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2021 |
| Most Recent Quarter (mrq) | March 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -20212.81% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.34% |
| Return on Equity (ttm) | -86.55% |
Income Statement
| Revenue (ttm) | 234K ILA |
| Revenue Per Share (ttm) | 0.007 ILA |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -46047000 ILA |
| Net Income Avi to Common (ttm) | -46805000 ILA |
| Diluted EPS (ttm) | -1.462 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 61.98M ILA |
| Total Cash Per Share (mrq) | 1.92 ILA |
| Total Debt (mrq) | 30.86M ILA |
| Total Debt/Equity (mrq) | 76.89 ILA |
| Current Ratio (mrq) | 8.222 |
| Book Value Per Share (mrq) | 1.178 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -37671000 ILA |
| Levered Free Cash Flow (ttm) | -19248376 ILA |
Profile of Pluristem Therapeutics Inc.
| Country | Israel |
| State | N/A |
| City | Haifa |
| Address | Building No. 5 |
| ZIP | 3508409 |
| Phone | 972 7 4710 8600 |
| Website | https://pluri-biotech.com/ |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 153 |
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Q&A For Pluristem Therapeutics Inc. Stock
What is a current PSTI.TA stock price?
Pluristem Therapeutics Inc. PSTI.TA stock price today per share is 360.9 ILA.
How to purchase Pluristem Therapeutics Inc. stock?
You can buy PSTI.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pluristem Therapeutics Inc.?
The stock symbol or ticker of Pluristem Therapeutics Inc. is PSTI.TA.
Which industry does the Pluristem Therapeutics Inc. company belong to?
The Pluristem Therapeutics Inc. industry is Biotechnology.
How many shares does Pluristem Therapeutics Inc. have in circulation?
The max supply of Pluristem Therapeutics Inc. shares is 32.1M.
What is Pluristem Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Pluristem Therapeutics Inc. PE Ratio is 0.00000000 now.
What was Pluristem Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Pluristem Therapeutics Inc. EPS is 0 ILA over the trailing 12 months.
Which sector does the Pluristem Therapeutics Inc. company belong to?
The Pluristem Therapeutics Inc. sector is Healthcare.